Benzbromarone

BNF:
10.1.4
Status:
Red
Decision Date:
May 2016
 

Comments

RED: The British Society for Rheumatology Guideline for the Management of Gout recommend that benzbromarone (and probenecid) are only available for the treatment of patients with gout in the UK on a named patient basis, and patients requiring these unlicensed drugs should be under the care of a Rheumatologist.

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app